HomeQuestion

How would you treat oligometastatic NSCLC (brain and bone) with Non-V600E BRAF mutations?

1 Answers

Mednet Member

Medical Oncology · University of Oklahoma Health Sciences Center

I would treat with chemo-pembro. Down the road, MEK inhibitors is a choice.